News and Trends 30 Jan 2018
Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic
Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid…
Medimmune
- Latest Posts
News and Trends 6 Apr 2017
How is Biotech Transforming Pharma’s R&D Model?
Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances and acquisitions play in this…
Best in Biotech 30 Jan 2017
The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge
Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an exciting entrepreneurial scene at the…
News and Trends 2 Jan 2017
An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics
The MultipleMS Consortium has been granted €15M by the EU Horizon 2020 to improve the treatment of multiple sclerosis using personalized…
ADVERTISEMENT
News and Trends 1 Dec 2016
7 European Institutions in the Largest Cancer Bioinformatics Collaboration
Europe's best companies using bioinformatics to tackle cancer will take part in a huge collaboration aimed at developing personalized cancer…
News and Trends 21 Jul 2016
‘Winner Antibody’ holds promise as universal Influenza A Vaccine
MedImmune and Humabs have reasons to be happy. Their candidate for an Influenza A vaccine has made it into well-known…
News and Trends 24 Mar 2016
Novel Antibody for Influenza gets FDA Fast-Track Approval
Humabs (Switzerland) has gotten some serious recognition for its antibody platform, as its candidates for Influenza have received FDA fast-track…
News and Trends 18 Dec 2015
64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives
Ablynx, the Alpaca Nanobody Biotech from Belgium, has completed target enrollment of the first-in-infant Phase I/IIa study with its anti-Respiratory…
News and Trends 26 Nov 2015
The UK-Israeli €378M Small-Molecule Offensive Against Migraines
The Israeli TEVA and UK Heptares Therapeutics (now owned by Japanese Sosei) have partnered up on novel drug therapies targeting…
News and Trends 20 Nov 2015
Get to Know the Top 50 Women in the UK’s Biotech Scene
The Movers & Shakers Report 2015 lists 50 of the Top female Bio-Entrepreneurs... here's a select few I found particularly…
ADVERTISEMENT
News and Trends 2 Nov 2015
How Big can be Small in Biotech – #BIO-Europe 2015 Keynote
As usual at BIO-Europe, the fair starts with an opening keynote, this time with speakers from Merck Healthcare, MedImmune/AstraZeneca and…
News and Trends 22 Oct 2015
For when it actually is Lupus: New Autoimmune Crisis Drug reaches Human Trials
ArGEN-X from Ghent (BE) and Breda (NL) has initiated its phase I human trials for Auto-immune diseases such as systemic…
News and Trends 11 Aug 2015
AstraZeneca’s Oncology Expansion Continues: MedImmune grabs Inovio’s Cancer Vaccine
The massive expansion of AstraZeneca's pipeline continues, as its biological subsidiary, MedImmune buys Inovio Pharmaceuticals' clinical-stage cancer vaccine that targets…
News and Trends 16 Jul 2015
Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever
Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private investors to push forward its T…
News and Trends 3 Jul 2015
Lilly Cooperates with Immunocore to Fight Skin Cancer
Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore's lead T cell receptor-based drug, IMCgp100 is tested in…
News and Trends 16 Jun 2015
Novartis Uses Antibodies from Cured Patients to Fight Viruses
Novartis just paid the bill to Humabs to use its out-licensed drug candidate in a Phase II clinical trial. This monoclonal…
ADVERTISEMENT
News and Trends 30 Sep 2014
New Collaboration for New Cancer Therapies
Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered into a collaboration to establish…